Search
for
Sort by
Research 181–210 of 1000+
- Chrousos syndrome: from molecular pathogenesis to therapeutic management
- Non polycystic ovary syndrome–related endocrine disorders associated with hirsutism
- Relationship between betacoronaviruses and the endocrine system: a new key to understand the COVID-19 pandemic—A comprehensive review
- Consequences of steroid-5α-reductase deficiency and inhibition in vertebrates
- Pharmacologic Treatment of Polycystic Ovary Syndrome
- Congenital adrenal hyperplasia
- Clinical manifestations of polycystic ovary syndrome
- Urinary 5-ene-steroid excretion in non-classical congenital adrenal hyperplasia due to 3β-hydroxysteroid dehydrogenase deficiency (NC-3BHSD)
- Polycystic ovary syndrome: An update on diagnosis and management
- Hyperandrogenism in Women: Polycystic Ovary Syndrome
- Signaling pathways and targeted therapeutic strategies for polycystic ovary syndrome
- Pharmacologic Modulation of Sebaceous Gland Activity: Mechanisms and Clinical Applications
- Common Baldness in Women
- Hair Disorders
- Comparison of flutamide and spironolactone in the treatment of hirsutism: a randomized controlled trial
- Clinical relevance of testosterone and dihydrotestosterone metabolism in women
- Hormonal treatment of acne vulgaris: an update
- Acquired scalp alopecia. Part I: A review
- 9 Pilosebaceous physiology in relation to hirsutism and acne
- Endocrine Influences on Hair Growth
- The antiandrogen enzalutamide downregulates TMPRSS2 and reduces cellular entry of SARS-CoV-2 in human lung cells
- Expression and roles of steroidogenic acute regulatory (StAR) protein in ‘non-classical’, extra-adrenal and extra-gonadal cells and tissues
- Idiopathic Hirsutism*
- ANTIANDROGEN AND HORMONAL TREATMENT OF ACNE
- Hair loss in elderly women
- 12 Treatment of hirsutism with 5α-reductase inhibitors
- Congenital adrenal hyperplasia
- Hormone therapy in acne
- Association of AR rs6152G/A gene polymorphism with susceptibility to polycystic ovary syndrome in Chinese women
- Reproductive outcomes of female patients with congenital adrenal hyperplasia due to 21-hydroxylase defi ciency